racemetirosine has been researched along with Cardiac Failure in 2 studies
alpha-Methyltyrosine: An inhibitor of the enzyme TYROSINE 3-MONOOXYGENASE, and consequently of the synthesis of catecholamines. It is used to control the symptoms of excessive sympathetic stimulation in patients with PHEOCHROMOCYTOMA. (Martindale, The Extra Pharmacopoeia, 30th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zelis, R | 1 |
| Clemson, B | 1 |
| Baily, R | 1 |
| Davis, D | 1 |
| Franciosa, JA | 1 |
| Schwartz, DE | 1 |
2 other studies available for racemetirosine and Cardiac Failure
| Article | Year |
|---|---|
Regulation of tissue noradrenaline in the rat myocardial infarction model of chronic heart failure.
Topics: alpha-Methyltyrosine; Animals; Arteries; Desipramine; Disease Models, Animal; Heart Failure; Kidney | 1992 |
Acute hemodynamic effects of norepinephrine inhibition in patients with severe chronic congestive heart failure.
Topics: Adult; Aged; alpha-Methyltyrosine; Drug Administration Schedule; Heart Failure; Hemodynamics; Humans | 1989 |